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about  the  cover :  Color-enhanced scanning electron micrograph of a stem cell collected
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The process of discovery is very
simple.An unwearied and 
systematic application of known
laws to nature causes the
unknown to reveal themselves.
—Henry David Thoreau
ealing,Teaching and Discovery.”
Undoubtedly, the general public
is most familiar with the first part
of the School of Veterinary
Medicine’s tri-fold mission—and
with good reason.The Matthew
J. Ryan Veterinary Hospital in
Philadelphia sees more than
28,000 companion-animal patient
visits each year, 12,000 of which
come through the Emergency Service.The George D.
Widener Hospital for Large Animals at New Bolton Center
accommodates more than 6,000 patient visits annually, and the
Hospital’s William Boucher Field Service sees more than
19,000 animals a year. Both Hospitals are known
internationally for their excellence in veterinary medical
specialties, many of which originated here: cardiology,
orthopaedics, oncology and medical genetics, to name only a
few. Dogs, cats, birds, reptiles, horses, cows, pigs—all these, and
more, can receive comprehensive treatment at Penn Veterinary
Medicine, perhaps the best care anywhere in the world.
Most people are not aware, though, that the Discovery com-
ponent of our mission undergirds the Healing and the Teaching
for which the School is internationally acclaimed. Knowledge
that emerges from the basic and clinical research of our scien-
tists allows us to develop new ways to diagnose and treat dis-
ease—and to impart those findings to the next generation of
veterinarians and researchers.As a partner in one of the world’s
great biomedical research and training centers, Penn Vet helps
both animals and people everywhere live longer, healthier
lives.Truly, biomedical research is the unsung hero of our
ongoing success story.
“
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Penn Veterinarians
Study the Big
Future for This
Little Cell
Building a Better Gene Trap
One area of research that is widely known
to most people is the study of stem cells, the
use of which is generating much optimism
for treating human and animal diseases. For
years, researchers at Penn and elsewhere
have sought to understand why the body
repairs and replaces some tissues, but not
others.After analyzing apparently indiscrim-
inant cell-repair mechanisms, scientists have
focused on stem cells; these cells have a spe-
cial capacity to renew themselves and form
a variety of specialized cell types. Stem cells
are capable of growing into any of the 300
different kinds of cells in the body.
Scientists distinguish between two types
of stem cells: adult and embryonic.Adult
stem cells exist in developed tissues in ani-
mals or humans after birth, supplying their
specific tissue with replacement cells
throughout life. (For example, our blood
stem cells produce five million cells per sec-
ond.) Adult stem cells can be isolated from
many parts of the body, including the brain,
but most commonly they are drawn from
the marrow in some bones. Compared to
embryonic stem cells, which come from
embryos and can make replacement cells for any tissue,
adult stem cells are normally dedicated to making cells for
one particular type. In other words, adult skin stem cells
usually can only make skin, not brain or blood cells. Most
experts agree, though, that the potential of stem cells to
prevent, diagnose and treat disease in both animals and
people is seemingly unlimited.
Dr. Ralph Brinster,V’60, GR’64, Richard King
Mellon Professor of Reproductive Physiology, is a pioneer
in the transplantation of certain stem cells known as
“germ cells,” which are the reproductive cells of the
body—eggs in females and sperm in males.“Stem cell
research is an area that has a lot of promise in terms of
biology and medicine,” he explained.“For example, stem
cells are responsible for maintenance of many tissues and
medical conditions, including cancer, so understanding
stem cells will help us understand disease.”
Dr. Brinster made international news in 1994 when he
transplanted the stem cells of one mouse into another.
When the stem cells became germ cells, they retained the
genes of the donor mouse. In an article published in the
February 2006 issue of Nature Clinical Practice, Dr. Brinster
describes a technique in which donor sperm cells from a
fertile male mouse can be transplanted to the testes of an
infertile male, where they can restore fertility. Eventually,
this procedure can offer hope to men who have become
sterile following chemotherapy or radiation treatment.
Working at New Bolton Center in Kennett Square, Pa.,
Dr. Ina Dobrinski, Dr.med.vet., M.V.Sc., Ph.D.,
Marion Dilly and David George Jones Chair in Animal
Reproduction and director of the School’s Center for
Animal Transgenesis and Germ Cell Research, acknowl-
edges that much of the research in her lab has its roots in
the germ cell technology that Dr. Brinster developed in
the mid-1990s. Dr. Dobrinski is applying information
derived from Dr. Brinster’s work in the mouse to non-
rodent animals, ultimately to improve the health and pro-
ductivity of farm animals through transplantation of male
germ cells whose genes have been manipulated.These
genetically altered animals and plants are called “trans-
genic” and can be of enormous value in medicine and
agriculture. In fact, transgenic animals were first created
here at Penn, in 1981.
“Going into the male germ-line for particular stem
cells was a very fascinating question because then the ani-
mal could just breed normally and transmit that fixed gene
or changed gene to its offspring,” said Dr. Dobrinski.“In
order to do that, to a certain degree we had to reinvent the
wheel:We had to redevelop the transplantation technique
[used in mice] because it doesn’t work the same way in
pigs or goats.We had to learn about those stem cells
because we don’t have the same reagents or antibodies
available as we have for mouse stem cells.” One aspect of
this work is the exploration of germ-line stem cell biology
to develop a new approach to transgenesis in domestic ani-
mals through the alteration of the male germ-line.
In the November/December 2005 issue of the Journal
of Andrology, Dr. Dobrinski and her colleagues relate
another way in which changing the genes of certain ani-
mals can be beneficial.“. . .Transgenic pigs play a central
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role as a potential source of tissues and organs for [trans-
plantation] to humans and are of increasing interest as
models for biomedical research. Similarly, transgenic dairy
goats are of significant economic value for the production
of biopharmaceutical proteins in their milk. . . .”
Another article co-authored by Dr. Dobrinski in the
same issue of the Journal of Andrology (published online
ahead of print) explains how stem cell transplantation can
help conserve species of animals that are endangered due
to loss of genetic diversity.“We are attempting to develop 
. . . stem cell transplantation [of undifferentiated sperm
cells] in the cat as a tool to preserve and propagate male
germplasm [DNA] from genetically valuable animals, be
they threatened wild species or lines of cats used as models
for inherited diseases.”
Mending a Broken Heart
Some 35 miles away from the Center for Animal Trans-
genesis and Germ Cell Research, Dr. Mark Oyama,
associate professor of cardiology at the Ryan Veterinary
Hospital, has studied how stem cell research might be used
to treat dogs with heart disease. Even with the development
of new technology and medications, even with an ever-
broadening knowledge base about the causes and courses of
heart disease, illness and death in dogs with heart problems
remains high.According to the American Veterinary
Medical Association, approximately 3.2 million dogs in the
United States that have annual veterinary examinations
suffer from some form of “acquired” heart disease and may
be in heart failure.
Dr. Oyama came to Penn last year from the University of
Illinois College of Veterinary Medicine, where he investi-
gated how damaged heart cells in dogs could be repaired by
transplanting the animals’ own stem cells into their hearts—
a process known as cardiac
cellular transplantation.
But the fundamental bio-
logical processes that gov-
ern the behavior of these
cells remains a mystery, as
does the long-term effica-
cy of the procedure.
“I think people get
excited about it because
of the huge potential that
it has,” Dr. Oyama said.
“Even in people, it’s an
area about which very lit-
tle is known.When
they’re doing stem cell
transplants in people, yes,
it appears to improve the
heart function, but when
you ask the scientists
‘How is it doing that?’
nobody knows.They don’t
have any idea. Cells go in
there, and somehow
they’re making the heart function better.”
Cardiac cellular transplantation already has been per-
formed in people who have suffered from heart attacks.
The early results suggest that a variety of adult stem cells
implanted in the heart are able to survive and grow into
cardiac-like muscle tissue,“rebuilding the heart one cell at
a time,” as Dr. Oyama wrote in Veterinary Medicine
(February 1, 2005).
Because a particular type of heart disease in dogs
involves much more of the heart than in people with a
similar disease, local injections of cells during surgery—
which is often used for people—would be inefficient for
dogs.“If the whole heart is diseased, that’s a lot harder. So
now you have to put in maybe 20 or 30 of these little
injections everywhere and hope that the cells spread out.
Every time you poke the heart, it’s conceivable that the
heart will have abnormal heart rhythms, it can bruise the
heart muscle and create lots of other problems,” Dr.
Oyama said.
One Medicine
One of the reasons that Dr. Oyama chose to come to Penn
was its unique position as part of a vast network of bio-
medical research facilities—and he has already begun to
take full advantage of the extraordinary opportunities this
offers.A certain kind of heart-valve disease in dogs resem-
bles that which occurs in some people who have taken the
diet drug “phen-fen” (a combination of phentermine and
fenfluramine). Dr. Oyama has begun work with Robert J.
Levy, M.D.,William J. Rashkind Endowed Chair in
Pediatric Cardiology at the Children’s Hospital of
Philadelphia, in looking at valve tissue in humans and try-
ing to better understand how a certain pathway involving
serotonin and transforming growth factor beta contributes
Cardiac cellular transplantation could have a marked effect in
treating dilated cardiomyopathy, or DCM, one of the most common
acquired heart diseases in large dogs. Some breeds, such as
Dobermans, great Danes and boxers, are particularly prone to it.
DCM causes the heart muscle to lose strength and fail to pump
blood properly, and can eventually lead to heart failure.To identify
genes that may play a role in the process of the disease, Dr. Oyama
and his colleagues at Illinois used a commercially available gene chip,
or microarray, designed for dogs—the GeneChip Canine Genome
Array—a 1.5-inch square that contains more than 23,000 genes.
When exposed to the genetic material from Doberman dogs that
had died from heart disease, genes on the chip fluoresced, or lit up,
if they were active in the sample.The researchers knew the nature
and location of the genes on the chip, so they could identify the
active genes in the samples and determine their level of activity by
the brightness of the fluorescence. Essentially all 23,000 genes,
tested at once, were narrowed down to 167 genes that could play
a role in the development of DCM.
Dr. Oyama and
Rudy
Photo by Sabina Louise Pierce
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to the disease. (Serotonin is a neurotransmitter believed to
play an important role in the regulation of mood, sleep,
vomiting, sexuality and appetite. Transforming growth factor
beta is one of many characterized growth factors that are
involved in tissue development, cell differentiation, embry-
onic development and many other signaling pathways.)
“We are doing some combined experiments to compare
mitral disease in dogs with mitral disease in humans,” Dr.
Oyama explained.“If similarities exist, we can look at the
dog as a model of disease for people, as well as apply what
we know about the human disease to figure out why older,
small-breed dogs are so predisposed to the disease.This com-
parative study hopes to merge Dr. Levy’s expertise in sero-
tonin valve disease with our expertise in the canine disease.”
Bred in the Bone
Cardiac tissue is not the only subject of stem cell research
at the School. In the Section of Surgery of the Department
of Clinical Studies–Philadelphia, Dr. Susan Volk,V’95,
GR’99, lecturer, has joined the faculty at Penn’s Medical
and Dental schools in studying how stem cells derived
from bone marrow can eventually become bone cells.
Most injured tissues heal by forming a scar, but injured
bone heals by actually forming new bone. Even in its
uninjured state, bone undergoes constant remodeling to
maintain its ability to move and support the body and to
sustain constant calcium levels. Both these processes—heal-
ing and remodeling—are dependent on undifferentiated
bone cells, as well as stem cells that can be induced to form
bone. If the recruitment, differentiation and/or induction
steps of new bone formation do not occur, the body can
develop orthopaedic disorders such as osteoporosis and
slow- or non-healing fractures. Because people in industri-
alized countries are living longer, orthopaedic disease is
having a greater economic impact on health-care resources.
This factor, as well as the significant decrease in quality of
life associated with these conditions, has made studies
involving orthopaedic disease a high priority within the
field of biomedical research.
Delayed bone healing in dogs requires extended medical
care, with prolonged patient illness and increased client
expense. Bone grafts using tissue from the patient’s own
body are frequently used to help bone union after surgery.
Several concerns, however, are associated with graft har-
vesting: problems or infection at the collection site,
increased anesthetic time and limited volume and donor
cell number. Bone-marrow stem cells (MSCs) are an
accepted source of bone-forming cells recruited during
normal bone growth, remodeling and fracture repair.
Therefore, they are logical agents for use in cell-based ther-
apies where induced bone growth is required. Pure popula-
tions of culture-expanded, inducible MSCs can be a potent
alternative to bone grafting with fewer complications.
Although MSCs enhance the repair of canine fractures
and bone gaps, the specific inducers necessary to cause
canine MSCs to become bone-forming cells have yet to be
identified.Although MSCs from all species studied can be
induced to eventually form bone cells, the potency of
inducers varies markedly from one species to the next.The
work of Dr.Volk and her colleagues, published in the
October 2005 issue of the American Journal of Veterinary
Research, suggests that differences exist in the most efficient
inducers of bone growth among species.“Defining which
growth factors are most efficient to induce [bone forma-
tion] in these cells has important clinical implications for
their use in cell-based therapies. In addition, we are defin-
ing differences that exist in the differentiation capacity of
these cells based on their source (i.e., site of bone-marrow
harvest and age of donor), which has important implica-
tions for the development of MSC-based therapies in our
small-animal surgical patients, as well as in humans,” Dr.
Volk explained.
In addition to Dr.Volk’s interest in MSCs for orthopaedic
applications, she is also investigating their use for soft-tissue
surgical applications. In collaboration with Drs. Kenneth
Liechty and Alan Flake at the Children’s Institute for
Surgical Science, Children’s Hospital of Philadelphia, she
has focused on establishing their effect in the treatment of
oxygen-deprived (ischemic) wounds and dissecting mecha-
nisms of their therapeutic effects. Complicated wound
healing imposes a formidable clinical challenge in both
human and veterinary medicine, with prolonged hospital-
ization and substantial health-care expenditure.To date,
effective therapies for ischemic ulcers and other chronic
non-healing wounds are lacking. Dr.Volk’s research suggests
that MSCs directly participate in wound healing and indi-
rectly influence surrounding cells to improve healing of
ischemic wounds. Studies are underway to characterize
how topical application of MSCs can improve the phases
of healing in ischemic wounds. Knowledge about tissue
engineering gained from this research can provide substan-
tial insight into molecular mechanisms critical for healing
chronic wounds and other ischemic tissues.
Full Steam Ahead
Research is the cornerstone on which Penn—and any
other research university, for that matter—must build its
future, on which medical science itself is perpetually bal-
anced. Stem cell technology has already revolutionized
modern biology and promises to provide unique opportu-
nities in understanding mechanisms behind basic biological
processes and in the treatment of disease.Among its count-
less applications in human and veterinary science,
researchers hope to eventually use stem cells to repair
spinal cords; cure Crohn’s,Alzheimer’s and Parkinson’s dis-
eases; re-grow arteries and limbs; replace damaged kidneys
and hearts; cure diabetes by substituting nonfunctioning
pancreatic cells; restore vision and hearing; and treat
leukemia, lymphoma and brain cancer. In fact, most of
these treatments have already been studied, and with prom-
ising results. Granted, years of additional research are still
necessary to realize this technology’s full therapeutic poten-
tial, but work at Penn Vet in the laboratories of researchers
like Drs. Brinster, Dobrinski, Oyama and Volk—and in labs
across campus and around the world—is proceeding full
steam ahead.
